Trend investing

You’d think it would be simple, wouldn’t you? Identify a long-term trend, invest your money in a company (or companies) that is playing this theme, and sit back and wait for the next 30 years or so. Unfortunately, that’s not the case.

A trend, by definition, is a movement in a general direction. The journey, especially if long, can take many different twists and turns and different people will take different routes to get to the same end point. In the same way, how you invest in a theme can change dramatically over time.

Take technology as an example. Technological advances are constantly changing the way we live our lives. It is a very entrepreneurial and exciting sector and, as a result of the rapid advances, it has changed considerably even in the past five years, let alone the past 30.

In the 1980s, Silicon Valley was the place to be and technology first started to became personal and portable, with PCs, mobile phones, Walkmans and videocassette players in the home. Even the most popular films in the cinema were all about our expectations of how technology would transform our lives in the future. Things don’t look quite as predicted in Back to the Future, although they seemed to get more right than wrong with tablet computers, hands-free gaming, wearable technology and video calls, but certainly we’ve moved on and the companies that are thriving have changed too. Today we’ve mobile banking, data storage and 3D printing. So you have to move with the times.

Valuations are mixed at the moment, but there are still opportunities to be found. ‘Security’ stocks are particularly interesting. They aren’t cheap, but they have the growth potential to justify the price being paid and it is an area where company IT spend is actually increasing.

Sometimes, a long-term theme is identified, but takes many years to start to come to fruition. Take demographics, or more specifically, the ageing population, for example. The healthcare sector should be a major beneficiary of this but actually had a ‘lost decade’ at the turn of the millennium. Nothing really happened. Then, boom, it took a global financial crisis and austerity to help it burst out of its trading range. The past five years have seen tremendous advances in the sector and investors have been well rewarded.

Pensions aside, healthcare is our biggest problem today. Healthcare spend in the US is now 17.5% of GDP. In Europe it is 8%-12%. In the UK we spend £110 billion on healthcare, 75% of which is on chronic diseases. It’s too much and the system is creaking. We have 20th century infrastructure trying to cope with 21st century problems. So companies that can reduce costs and increase productivity, especially for governments, are now thriving.

Healthcare consumerism is also growing: we are starting to take control of our primary care and more and more people are willing to pay for faster, better service. For example, a vial of flu vaccine in the UK costs about £5. By the time you’ve booked an appointment, sat in a doctor’s waiting room and seen a nurse for the jab, it costs the NHS about £25. In the US, companies like CVS (similar to Boots in the UK) do walk-in flu jabs that cost you $20. Healthcare insurance in the US really only covers the big expenditures, as you pay the first $4-5,000 yourself (the equivalent of ‘excess’ on insurance here). A standard doctor’s appointment is between $100-200, so you can see why a $20 flu jab is so appealing.

If you like thematic investing, Elite Rated funds which play to the subjects in this article include AXA Framlington Global Technology, Polar Capital Global Healthcare Opportunities and Liontrust Macro UK Equity Income. The latter is in a popular sector but does something different, investing in a number of long-term themes. The core philosophy of the fund is that macro-thematic analysis and the identification of economic, political and social developments are key to outperformance. The fund focuses on major factors affecting the world, such as global warming, globalisation and ageing populations. They also focus on negative themes to avoid certain sectors. As a result, they don’t own any incumbent banks, utility or tobacco companies.

This article is provided for information only. The views of the author and any people quoted are their own and do not constitute financial advice. The content is not intended to be a personal recommendation to buy or sell any fund or trust, or to adopt a particular investment strategy. However, the knowledge that professional analysts have analysed a fund or trust in depth before assigning them a rating can be a valuable additional filter for anyone looking to make their own decisions. Past performance is not a reliable guide to future returns. Market and exchange-rate movements may cause the value of investments to go down as well as up. Yields will fluctuate and so income from investments is variable and not guaranteed. You may not get back the amount originally invested. Tax treatment depends of your individual circumstances and may be subject to change in the future. If you are unsure about the suitability of any investment you should seek professional advice. Whilst FundCalibre provides product information, guidance and fund research we cannot know which of these products or funds, if any, are suitable for your particular circumstances and must leave that judgement to you. Before you make any investment decision, make sure you’re comfortable and fully understand the risks. Further information can be found on Elite Rated funds by simply clicking on the name highlighted in the article.